Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance. (Q51569047)

7 April 2018

title

Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance. (English)

1 reference

7 April 2018

0 references

1 reference

Toft I

1

1 reference

7 April 2018

Bønaa KH

series ordinal

2

1 reference

7 April 2018

Lindal S

series ordinal

3

1 reference

7 April 2018

Jenssen T

series ordinal

4

1 reference

7 April 2018

publication date

1 July 1998

1 reference

7 April 2018

published in

Metabolism

1 reference

7 April 2018

volume

47

1 reference

7 April 2018

issue

7

1 reference

7 April 2018

page(s)

848-854

1 reference

7 April 2018

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Islet dysfunction in obese women with impaired glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Development of impaired glucose tolerance with or without weight gain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

What causes impaired glucose tolerance to deteriorate or normalize?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Impaired glucose tolerance in the U.S. population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Muscle fiber composition and capillary density in women and men with NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Glucose tolerance and hyperinsulinaemia in obese women: role of adipose tissue distribution, muscle fibre characteristics and androgens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Metabolic implications of body fat distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

The effect of insulin-induced hypoglycemia with and without atropine on plasma GIP in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Decreased insulin removal contributes to hyperinsulinemia in obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

A quick, simple and reliable histochemical method for ATPase in human muscle preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Muscle morphometry in motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

RAPID EXAMINATION OF MUSCLE TISSUE. AN IMPROVED TRICHROME METHOD FOR FRESH-FROZEN BIOPSY SECTIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Relationships Between Intravenous Glucose Loads, Insulin Responses and Glucose Disappearance Rate1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

The morphology and metabolism of intraabdominal adipose tissue in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Muscle fibre type and aetiology of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990125-1

10.1016/S0026-0495(98)90125-1

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9667234

1 reference

7 April 2018